marijuana stock news

Form 8-K for SURNA INC.


Change in Directors or Principal Officers, Other Events, Financial Statements and Exhi

Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.On February 24, 2015, Tom Bollich submitted his resignation as President, Chief Executive Officer, Chairman of the Board and a member of the Board of Directors of Surna, Inc. (“Surna” or the “Company”), effective April 15, 2015. Mr. Bollich did not resign because of a disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

Bryon Jorgenson will succeed Mr. Bollich as CEO of Surna. Mr. Jorgenson joined the Company in January as Chief Operating Officer as disclosed in Surna’s Form 8-K filed January 8, 2015 (which is incorporated herein by reference). He has more than 25 years of experience at the executive-level and as an engineer in industrial electronics, life sciences and industrial automation systems. His career has focused on business development functions including product commercialization, pre-acquisition due diligence, business integration, management team transition, and operations performance improvement.


Item 8.01. Other Events.On February 26, 2015, the Company issued a press release regarding Mr. Bollich’s resignation and appointment of Bryon Jorgenson as his successor. The press release is attached hereto as Exhibit 99.1.

The information contained in the press release attached hereto is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that Section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


Item 9.01. Financial Statements and Exhibits.(d) Exhibits.

Exhibit No.   Description of Exhibit

    8.1       Chief Operating Officer Employment Agreement (incorporated herein by
              reference to Exhibit 10.1 to the Company's Report on Form 8-K as
              filed with the Securities and Exchange Commission on January 8,

    8.2       Executive Officer Confidentiality, Non-competition and
              Non-solicitation Agreement (incorporated herein by reference to
              Exhibit 10.2 to the Company's Report on Form 8-K as filed with the
              Securities and Exchange Commission on January 8, 2015)

   99.1       Press release of the Company dated February 26, 2015.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Marijuana Stocks Newsletter – Thursday Morning Update – January 10, 2019

Premier Health (OTC:PHGRF) (CSE:PHGI) Signs Definitive Agreement for Acquisition of Cloud Practice…

$PMCB Executives Interviewed on Role of Leaders in Oncology

PharmaCyte Biotech Executives Interviewed on Role of Leaders in Oncology for Development…